Germany, June 3 -- BASF has begun the registration process for its new fungicide innovation Adapzo(R) Active (Flufenoxadiazam) and submitted the regulatory dossiers to the relevant authorities in Brazil and Paraguay, with a subsequent submission planned in Bolivia. This new active ingredient from BASF's robust innovation pipeline is the industry's first histone deacetylase (HDAC) inhibitor. Building on BASF's history in innovative disease control for soybeans, Adapzo Active marks a major milestone in the company's efforts to offer farmers a much-needed novel mode of action, delivering an unprecedented level of Asian Soybean Rust (ASR) control. Pending regulatory approvals, BASF expects first market introductions of Adapzo Active-based formu...